A novel approach to Parkinson’s disease treatment with a potentially dual-acting therapeutic agent that targets α-synuclein aggregation and neuron death Neural Regeneration Research . 2024, (12): 2577 -2578 .  DOI: 10.4103/NRR.NRR-D-23-01934